Clinical Development of the CDK4/6 Inhibitors Ribociclib and Abemaciclib in Breast Cancer

Publisher: Karger

E-ISSN: 1661-3805|11|3|167-173

ISSN: 1661-3791

Source: Breast Care, Vol.11, Iss.3, 2016-06, pp. : 167-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract